FDA Inspection 862502 — Matthew W. Doust, MD

Matthew W. Doust, MD — FEI 3010593279

The FDA completed an inspection of Matthew W. Doust, MD on Jan 15, 2014 in Phoenix, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 15, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Phoenix, AZ (United States)

Additional Details

Clinical Investigator (CI)